Cargando…

Heart failure labelled patients with missing ejection fraction in primary care: prognosis and determinants

BACKGROUND: It is common to find a high variability in the accuracy of heart failure (HF) diagnosis in electronic primary care medical records (EMR). Our aims were to ascertain (i) whether the prognosis of HF labelled patients whose ejection fraction (EF) was missing in their EMR differed from those...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz, Miguel-Angel, Mundet-Tuduri, Xavier, Real, Jordi, Del Val, José-Luis, Domingo, Mar, Vinyoles, Ernest, Calero, Ester, Checa, Caterina, Soldevila-Bacardit, Nuria, Verdú-Rotellar, José-María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356293/ https://www.ncbi.nlm.nih.gov/pubmed/28302060 http://dx.doi.org/10.1186/s12875-017-0612-6

Ejemplares similares

Short-term mortality in end-stage heart failure patients
por: Verdú-Rotellar, Jose Maria, et al.
Publicado: (2020)

Burden of heart failure in primary healthcare
por: Gonzalez-Loyola, Felipe-Estuardo, et al.
Publicado: (2022)

Living with advanced heart failure: A qualitative study
por: Checa, Caterina, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Prognostic value of non-specific ST-T changes and left ventricular hypertrophy electrocardiographic criteria in hypertensive patients: 16-year follow-up results from the MINACOR cohort
por: Vinyoles, Ernest, et al.
Publicado: (2015)

Does defibrillation threshold increase as left ventricular ejection fraction decreases?
por: Val-Mejias, Jesus E., et al.
Publicado: (2010)

Relationship between the place of living and mortality in patients with advanced heart failure
por: Muñoz, Miguel-Angel, et al.
Publicado: (2020)

Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study
por: Verdú-Rotellar, Jose María, et al.
Publicado: (2017)

Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes
por: Barrot, Joan, et al.
Publicado: (2022)

Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study
por: Muñoz, Miguel Angel, et al.
Publicado: (2022)

Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study
por: Mauricio, Didac, et al.
Publicado: (2022)

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study
por: Vlacho, Bogdan, et al.
Publicado: (2021)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2023)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
por: Bayes-Genis, Antoni, et al.
Publicado: (2021)

Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
por: Vicent, Lourdes, et al.
Publicado: (2023)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort
por: Forés, Rosa, et al.
Publicado: (2018)

Correction: Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort
por: Forés, Rosa, et al.
Publicado: (2018)

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
por: Gastelurrutia, Paloma, et al.
Publicado: (2018)

Diabetes Associated With Greater Ejection Fraction Improvement After Revascularization in Patients With Reduced Ejection Fraction
por: Wang, Shaoping, et al.
Publicado: (2021)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
por: Miller, Robert J.H., et al.
Publicado: (2022)

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
por: Shahnazaryan, Syuzanna, et al.
Publicado: (2023)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Expectations and perceptions of primary healthcare professionals regarding their own continuous education in Catalonia (Spain): a qualitative study
por: Mundet-Tuduri, Xavier, et al.
Publicado: (2017)

Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
por: Barrot‐de la Puente, J., et al.
Publicado: (2015)

Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis
por: Zamora, Elisabet, et al.
Publicado: (2022)

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction
por: Kahn, Matthew, et al.
Publicado: (2021)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
por: Codina, Pau, et al.
Publicado: (2022)

Neurovascular Coupling Impairment in Heart Failure with Reduction Ejection Fraction
por: Aires, Ana, et al.
Publicado: (2020)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
por: Lupón, Josep, et al.
Publicado: (2021)

Systems Biology Applied to Heart Failure With Normal Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2014)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Supervised Analysis for Phenotype Identification: The Case of Heart Failure Ejection Fraction Class
por: Lopez, Cristina, et al.
Publicado: (2021)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jccrqgnlq4r2l5amikt43j48un